By identifying a molecule that delays the progression of MS, CRCHUM researchers pave the way for new therapies for the nearly 77,000 Canadians living with the disease.
UdeM medical professor Cara Tannenbaum discusses a piece she wrote with colleagues in the U.K., U.S. and Germany for the 150th anniversary of the scientific journal Nature.
Renewed cracking of the genetic code – we may have just begun to scratch the surface.
The largest-ever collection of home movies made by East Germans has been digitized and made accessible online for general viewing, lifting the veil on hundreds of forgotten stories of totalitarianism.
In a Phase One-Two clinical trial, the vast majority of patients with blood cancers are on the road to recovery, thanks to the UM171 molecule, discovered at the IRIC of the UdeM.
On December 5-6, the Université de Montréal will bring together students and scholars from Montréal’s universities to discuss the essential role of rhythm in various disciplines.
Dr Christopher E. Rudd has discovered a new cell therapy approach that boosts the immune response of T lymphocytes to malignant tumours.
In the weeks following his return to Earth, David Saint-Jacques was treated by several health professionals, including osteopath René Pelletier, a University de Montréal graduate.
A new Canadian public health campaign is launched to promote the importance of getting a good night's rest.
For years, the old Outremont Train Yard was a long scar on Montréal’s urban landscape. Now a new neighbourhood is taking shape there, centred around the Université de Montréal’s new MIL Campus.
Three years after the first shovelful of earth was turned, the Science Complex at the MIL Campus welcomes the university community.
An international research team is perfecting a method to predict the potential clinical implications of new drugs before clinical trials even start.